metricas
covid
Buscar en
Revista Española de Geriatría y Gerontología
Toda la web
Inicio Revista Española de Geriatría y Gerontología Hipertrofia benigna de próstata: delimitación entre la enfermedad y la simple ...
Información de la revista
Vol. 42. Núm. 5.
Páginas 255-256 (septiembre 2007)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 42. Núm. 5.
Páginas 255-256 (septiembre 2007)
Editorial
Acceso a texto completo
Hipertrofia benigna de próstata: delimitación entre la enfermedad y la simple manifestación del proceso de envejecimiento
Visitas
3669
Ignacio Pereira Sanz, Manuel Fernández Arjona
Servicio de Urología. Hospital Universitario La Princesa. Madrid. España
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S.J. Berry, D.S. Coffey, P.C. Walsh.
The development of human prostatic hyperplasia with age.
J Urol, 132 (1984), pp. 474-479
[2.]
J.E. Oesterling, S.J. Jacobsen, C.G. Chute.
Serum prostate-specific antigen in a community-based population of health men: establishment of age specific reference ranges.
JAMA, 270 (1993), pp. 860-864
[3.]
M.J. Barry, M.P. O’Leary.
The development and clinical utility of symptom scores.
Urol Clin N Am, 22 (1995), pp. 229-307
[4.]
C.J. Girman, S.J. Jacobsen, H.A. Guess.
Natural history of prostatism: relationship among symptoms, prostate volume and peak flow rate.
J Urol, 153 (1995), pp. 1510-1515
[5.]
M.J. Barry, A.T.K. Cockett, H.L. Holtgreve.
Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of severity of benign prostatic hyperplasia.
J Urol, 150 (1993), pp. 351-358
[6.]
T. Tsukamoto, Y. Kumamoto, N. Masumori.
Prevalence of prostatism in Japanese men in a population-based study with comparison to a similar American study.
J Urol, 154 (1995), pp. 391-395
[7.]
D.I. Gup, E. Shapiro, M. Barman.
Autonomic receptors in asymptomatic and symptomatic BPH.
J Urol, 143 (1990), pp. 179-185
[8.]
E. Shapiro, M.J. Beccih, H. Lepor.
The relative proportion of estromal and epithelial hyperplasia as related to the development of clinical BPH.
J Urol, 147 (1992), pp. 1293-1297
[9.]
H. Lepor, E. Shapiro, R. Browsher.
Tissue norepinephrine levels in prostate adenomas from men with symptomatic and asymptomatic BPH.
J Urol, 144 (1990), pp. 1263-1266
[10.]
E. Shapiro, V. Hartano, H. Lepor.
The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle.
Prostate, 21 (1992), pp. 297-307
[11.]
S.J. Jacobsen, D.J. Jacobson, C.J. Girman.
Natural history of prostatism: risk factor for acute urinary retention.
J Urol, 158 (1997), pp. 481-487
[12.]
J.D. McConnel, R. Bruskewitz, P.C. Wals.
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia.
N Engl J Med, 338 (1998), pp. 557-563
[13.]
H. Lepor, G. Machi.
A comparison of the AUA symptoms index in unselected males and females between the ages of 55-79 years of age.
Urology, 42 (1993), pp. 36-45
[14.]
M.J. Barry, F.J. Fowler, M.P. O’Leary.
The American Urological association symptom index for benign prostatic hyperplasia.
J Urol, 148 (1992), pp. 1549-1558
Copyright © 2007. Sociedad Española de Geriatría y Gerontología
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos